Company · CIK 1946399
LakeShore Biopharma Co., Ltd.
| CIK | 1946399 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | E9 |
| Business address | China |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2023-07-26 |
Offerings
1 registration| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-271221 | 2023-04-12 | 2024-01-25 | 5 |
Filings
7| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-01-25 | EFFECTDeclared effective | 333-271221 | 9999999995-24-000203 |
| 2023-08-10 | EFFECTDeclared effective | 333-271221 | 9999999995-23-002337 |
| 2023-06-05 | EFFECTDeclared effective | 333-271221 | 9999999995-23-001629 |
| 2023-05-12 | F-1/AAmendment | 333-271221 | 0001104659-23-059711 |
| 2023-04-12 | F-1Registration filed | 333-271221 | 0001104659-23-044356 |
| 2023-02-07 | EFFECTDeclared effective | 333-269031 | 9999999995-23-000294 |
| 2022-10-03 | DRSDraft made public | 377-06394 | 0001104659-22-104874 |